학술논문
CD34+ cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina
Document Type
Article
Author
Source
In: Stem Cells Translational Medicine . (Stem Cells Translational Medicine, 1 October 2020, 9(10):1147-1152)
Subject
Language
English
ISSN
21576580
21576564
21576564